CN105272918B - Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes - Google Patents
Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes Download PDFInfo
- Publication number
- CN105272918B CN105272918B CN201510808967.7A CN201510808967A CN105272918B CN 105272918 B CN105272918 B CN 105272918B CN 201510808967 A CN201510808967 A CN 201510808967A CN 105272918 B CN105272918 B CN 105272918B
- Authority
- CN
- China
- Prior art keywords
- triarylimidazoles
- vinyl
- reaction
- solvent
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920002554 vinyl polymer Polymers 0.000 title claims description 16
- 238000002360 preparation method Methods 0.000 title claims description 5
- 230000026030 halogenation Effects 0.000 title 1
- 238000005658 halogenation reaction Methods 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000002904 solvent Substances 0.000 claims abstract description 22
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002608 ionic liquid Substances 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 26
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 20
- -1 dichloromethane Alkane Chemical class 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 17
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 238000003786 synthesis reaction Methods 0.000 claims description 11
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 10
- 239000005695 Ammonium acetate Substances 0.000 claims description 10
- 229940043376 ammonium acetate Drugs 0.000 claims description 10
- 235000019257 ammonium acetate Nutrition 0.000 claims description 10
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 claims description 10
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 claims description 8
- 239000011553 magnetic fluid Substances 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 239000000575 pesticide Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 239000013067 intermediate product Substances 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 125000001033 ether group Chemical group 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 claims 6
- 239000003513 alkali Substances 0.000 claims 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims 2
- 238000009413 insulation Methods 0.000 claims 2
- 239000005977 Ethylene Substances 0.000 claims 1
- 229940095076 benzaldehyde Drugs 0.000 claims 1
- 150000002012 dioxanes Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229940031098 ethanolamine Drugs 0.000 claims 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract description 84
- 150000002460 imidazoles Chemical class 0.000 abstract description 19
- 150000008282 halocarbons Chemical class 0.000 abstract description 4
- 238000001308 synthesis method Methods 0.000 abstract description 3
- 239000007787 solid Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000178 monomer Substances 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 125000006575 electron-withdrawing group Chemical group 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 239000008204 material by function Substances 0.000 description 3
- NJTKSIWHQXYDBS-UHFFFAOYSA-N 2-(2,4,5-triphenylimidazol-1-yl)ethanol Chemical compound OCCN1C(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 NJTKSIWHQXYDBS-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Chemical group 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000005594 diketone group Chemical group 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000011630 iodine Chemical group 0.000 description 2
- 229910052740 iodine Chemical group 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及下式(I)的卤化‑1‑烃基‑3‑乙烯基‑2,4,5‑三芳基咪唑及其合成方法和作为离子液体用于提高反应产率的用途。本发明的方法包括将1‑乙烯基‑2,4,5‑三芳基咪唑和卤代烃(例如R4X,如碘甲烷)加入溶剂中,搅拌均匀后加热并保温反应液至反应结束,蒸除溶剂后,残余物经洗涤、过滤分离、真空干燥,得到卤化‑1‑烃基‑3‑乙烯基‑2,4,5‑三芳基咪唑。本发明的卤化‑1‑烃基‑3‑乙烯基‑2,4,5‑三芳基咪唑的合成方法操作简单,具有较高的实用价值。 The present invention relates to a halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazole of the following formula (I), a synthesis method thereof, and the use thereof as an ionic liquid for increasing reaction yield. The method of the present invention comprises adding 1-vinyl-2,4,5-triaryl imidazoles and halogenated hydrocarbons (for example R X , such as methyl iodide) into the solvent, stirring evenly and then heating and insulated the reaction solution until the end of the reaction, After distilling off the solvent, the residue was washed, separated by filtration, and dried in vacuum to obtain halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triarylimidazole. The synthesis method of the halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazole of the present invention is simple to operate and has high practical value.
Description
技术领域technical field
本发明属于化学合成技术领域,特别是涉及卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑,例如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑,及在一个反应体系内合成卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑例如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑的方法及其作为离子液体用于提高反应产率的用途。The invention belongs to the technical field of chemical synthesis, in particular to halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazoles, such as iodide-1-methyl-3-vinyl-2,4, 5-Triaryl imidazoles, and the synthesis of halogenated 1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazoles such as iodide-1-methyl-3-vinyl-2,4 in one reaction system , Process for 5-triaryl imidazoles and their use as ionic liquids for increasing reaction yields.
背景技术Background technique
咪唑类化合物都是重要的有机化合物,其作为中间体或最终产物在有机合成、药物合成、农药、造纸及功能材料等领域都有着极其广泛的应用,尤其在精细化工品的生产中占有着极为重要的地位。多年来,咪唑类化合物的合成方法的研究一直是有机化学界的热门课题之一。Imidazole compounds are important organic compounds, which are widely used as intermediates or final products in the fields of organic synthesis, pharmaceutical synthesis, pesticides, papermaking and functional materials, especially in the production of fine chemicals. Important position. For many years, the research on the synthesis method of imidazole compounds has been one of the hot topics in the field of organic chemistry.
现有技术中,常见的合成具有取代基的咪唑的方法都是由二酮和醛在胺(铵)的作用下合环生成。在二酮作用下一步同时生成咪唑的方法尚未见文献报道。In the prior art, common methods for synthesizing imidazoles with substituents are all formed by ring closure of diketones and aldehydes under the action of amines (ammonium). The method of simultaneously generating imidazole in the second step of diketone action has not been reported in the literature.
发明内容Contents of the invention
本发明的要解决的技术问题是提供卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑,例如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑及在一个反应体系内合成卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑例如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑的方法,该方法操作简单,具有较高的实用价值。The technical problem to be solved in the present invention is to provide halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazoles, such as iodide-1-methyl-3-vinyl-2,4,5 - Triaryl imidazoles and their synthesis in one reaction -The method of triaryl imidazole, the method is simple to operate and has high practical value.
首先,本发明提供一种N-乙烯基三芳基咪唑化合物,其具有如下通式(II):First, the present invention provides a kind of N-vinyl triaryl imidazole compound, it has following general formula (II):
其中,通式II中R1、R2、R3基团相同或不相同,取代基R1、R2、R3各自独立地是氢或给电子基团或吸电子基团。例如C1-C10给电子基团,或卤素吸电子基团或硝基(吸电子基团)或(C1-C4)吸电子基团,如CN或三氟甲基。Wherein, the R 1 , R 2 , and R 3 groups in the general formula II are the same or different, and the substituents R 1 , R 2 , and R 3 are each independently hydrogen or an electron-donating group or an electron-withdrawing group. For example C1-C10 electron-donating groups, or halogen electron-withdrawing groups or nitro (electron-withdrawing groups) or (C1-C4) electron-withdrawing groups, such as CN or trifluoromethyl.
优选,所述的给电子基团选自氨基-NH2、-NHR5、-N(R6)2、C1-C6烷基、C1-C6烷氧基或C1-C6氨酰基。Preferably, the electron-donating group is selected from amino-NH 2 , -NHR 5 , -N(R 6 ) 2 , C 1 -C 6 alkyl, C 1 -C 6 alkoxy or C 1 -C 6 aminoacyl.
优选,所述的吸电子基团选自卤素原子、C1-C6羧基、C1-C6酯基、氰基、磺酸基。Preferably, the electron-withdrawing group is selected from halogen atoms, C 1 -C 6 carboxyl groups, C 1 -C 6 ester groups, cyano groups, and sulfonic acid groups.
优选,R5、R6各自独立地是氢、卤素、或C1-5烷基。Preferably, R 5 and R 6 are each independently hydrogen, halogen, or C1-5 alkyl.
优选,取代基R1的C原子数为1~5,R3和R2基团的C原子数量为1~5;优选地,当R1的C原子数量为1~5时,R1在苯环a所剩五个取代位置的任意位置;当R2的C数量为1~5时,R2可以在苯环b所剩五个取代位置的任意位置;和/或当R3的C数量为1~5时,R3可以在苯环c所剩五个取代位置的任意位置。Preferably, the number of C atoms in the substituent R1 is 1-5, and the number of C atoms in the groups R3 and R2 is 1-5; preferably, when the number of C atoms in R1 is 1-5, R1 is in Any position of the remaining five substitution positions of benzene ring a; when the number of C in R 2 is 1 to 5, R 2 can be in any position of the remaining five substitution positions of benzene ring b; and/or when the C of R 3 When the number is 1-5, R 3 can be in any of the remaining five substitution positions of the benzene ring c.
本发明还提供制备上述通式(II)的N-乙烯基三芳基咪唑化合物的方法,该方法包括:The present invention also provides a method for preparing the N-vinyl triaryl imidazole compound of the above general formula (II), the method comprising:
(A)将联苯甲酰、苯甲醛、醋酸铵、乙醇胺和纳米Fe3O4磁流体的混合物在溶剂中加热回流,反应结束后冷却,重结晶后获得N-羟乙基-2,4,5-三芳基咪唑;(A) Heat the mixture of dibenzoyl, benzaldehyde, ammonium acetate, ethanolamine and nano-Fe 3 O 4 magnetic fluid to reflux in a solvent, cool down after the reaction, and obtain N-hydroxyethyl-2,4 after recrystallization ,5-triaryl imidazole;
(B)让N-羟乙基-2,4,5-三芳基咪唑与三溴化磷升温反应,反应后冷却,经重结晶后获得N-溴乙基-2,4,5-三芳基咪唑;(B) Let N-hydroxyethyl-2,4,5-triaryl imidazole react with phosphorus tribromide, cool after reaction, and obtain N-bromoethyl-2,4,5-triaryl after recrystallization imidazole;
(C)让N-溴乙基-2,4,5-三芳基咪唑)与碱(例如氢氧化钾或氢氧化钠)回流反应,进行分离(例如柱分离),获得通式(II)的N-乙烯基三芳基咪唑化合物。(C) let N-bromoethyl-2,4,5-triaryl imidazole) and base (such as potassium hydroxide or sodium hydroxide) reflux reaction, carry out separation (such as column separation), obtain general formula (II) N-vinyl triaryl imidazole compounds.
优选,在步骤(A)中,联苯甲酰、苯甲醛、醋酸铵、乙醇胺四者的摩尔比是0.5~1.5:0.5~1.5:0.5~1.5:0.5~1.5,优选0.8~1.2:0.8~1.2:0.8~1.2:0.8~1.2。纳米Fe3O4磁流体的量可以变化很大,例如可以是以上述四者总重量为基础的5-80wt%,10~50wt%,如30wt%。Preferably, in step (A), the molar ratio of dibenzoyl, benzaldehyde, ammonium acetate and ethanolamine is 0.5-1.5: 0.5-1.5: 0.5-1.5: 0.5-1.5, preferably 0.8-1.2: 0.8- 1.2: 0.8~1.2: 0.8~1.2. The amount of nano-Fe 3 O 4 magnetic fluid can vary greatly, for example, it can be 5-80wt%, 10-50wt%, such as 30wt% based on the total weight of the above four.
优选,在步骤(B)中,N-羟乙基-2,4,5-三芳基咪唑与三溴化磷的摩尔比是1:1~4,优选1:1.5~2.5。Preferably, in step (B), the molar ratio of N-hydroxyethyl-2,4,5-triaryl imidazole to phosphorus tribromide is 1:1-4, preferably 1:1.5-2.5.
优选,在步骤(C)中,N-溴乙基-2,4,5-三芳基咪唑)与碱的摩尔比是1:2~6,优选1:3~4。Preferably, in step (C), the molar ratio of N-bromoethyl-2,4,5-triaryl imidazole) to base is 1:2-6, preferably 1:3-4.
以N-乙烯基三苯基咪唑化合物为例,其反应路线如下所示:Taking N-vinyltriphenylimidazole compound as an example, its reaction scheme is as follows:
本发明的技术方案概括如下:Technical scheme of the present invention is summarized as follows:
1、通式(I)的卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑:1. Halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazoles of general formula (I):
其中,通式I中R1、R2、R3基团相同或不相同,取代基R1、R2、R3各自独立地是氢或给电子基团或吸电子基团;R4是烃基,例如C1-C8烃基,优选C1-C6烃基,如C1-C6烷基;X是氟、氯、溴或碘。Wherein, the R 1 , R 2 , and R 3 groups in the general formula I are the same or different, and the substituents R 1 , R 2 , and R 3 are each independently hydrogen or an electron-donating group or an electron-withdrawing group; R 4 is Hydrocarbyl, such as C 1 -C 8 hydrocarbon, preferably C 1 -C 6 hydrocarbon, such as C 1 -C 6 alkyl; X is fluorine, chlorine, bromine or iodine.
优选,所述的给电子基团选自氨基-NH2、-NHR5、-N(R6)2、C1-C6烷基、C1-C6烷氧基或C1-C6氨酰基。Preferably, the electron-donating group is selected from amino-NH 2 , -NHR 5 , -N(R 6 ) 2 , C 1 -C 6 alkyl, C 1 -C 6 alkoxy or C 1 -C 6 aminoacyl.
优选,所述的吸电子基团选自卤素原子、C1-C6羧基、C1-C6酯基、氰基、磺酸基,Preferably, the electron-withdrawing group is selected from halogen atoms, C 1 -C 6 carboxyl groups, C 1 -C 6 ester groups, cyano groups, sulfonic acid groups,
优选,R5、R6各自独立地是氢、卤素、或C1-5烷基。Preferably, R 5 and R 6 are each independently hydrogen, halogen, or C1-5 alkyl.
优选,取代基R1的C原子数为1~5,R3和R2基团的C原子数量为1~5。Preferably, the substituent R 1 has 1-5 C atoms, and the R 3 and R 2 groups have 1-5 C atoms.
优选,当R1的C原子数量为1~5时,R1在苯环a所剩五个取代位置的任意位置。当R2的C数量为1~5时,R2可以在苯环b所剩五个取代位置的任意位置。当R3的C数量为1~5时,R3可以在苯环c所剩五个取代位置的任意位置。Preferably, when the number of C atoms in R 1 is 1-5, R 1 is at any of the remaining five substitution positions of benzene ring a. When the number of C in R 2 is 1-5, R 2 can be in any of the remaining five substitution positions of benzene ring b. When the number of C in R 3 is 1-5, R 3 can be in any position of the remaining five substitution positions of benzene ring c.
2、制备以上通式(I)的卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑的方法,2. The method for preparing the halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazole of the above general formula (I),
其中,通式I中R1、R2、R3、R4和X如以上所定义;Wherein, R 1 , R 2 , R 3 , R 4 and X in general formula I are as defined above;
所述方法包括:The methods include:
将下式(II)的1-乙烯基-2,4,5-三芳基咪唑:With the 1-vinyl-2,4,5-triaryl imidazole of the following formula (II):
其中取代基R1、R2、R3如以上所定义,Wherein the substituents R 1 , R 2 , R 3 are as defined above,
和卤代烃R4X(其中R4是烃基,例如C1-C8烃基,优选C1-C6烃基,如C1-C6烷基;和其中X是氟、氯、溴或碘;卤代烃R4X例如是碘甲烷)加入溶剂中,搅拌均匀后加热(优选加热到回流状态,通常50-100℃,优选50~90℃,更优选60~70℃,更优选60~65℃)并将反应液进行保温反应(通常8~12小时)直至反应结束,蒸除溶剂后,残余物经洗涤、过滤分离、真空干燥,得到通式(I)的卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑。and halogenated hydrocarbons R 4 X (wherein R 4 is a hydrocarbon group, such as a C 1 -C 8 hydrocarbon group, preferably a C 1 -C 6 hydrocarbon group, such as a C 1 -C 6 alkyl group; and wherein X is fluorine, chlorine, bromine or iodine ; Halogenated hydrocarbon R 4 X such as methyl iodide) is added to the solvent, heated after stirring (preferably heated to reflux state, usually 50-100 ° C, preferably 50-90 ° C, more preferably 60-70 ° C, more preferably 60- 65° C.) and the reaction solution was subjected to heat preservation reaction (usually 8 to 12 hours) until the end of the reaction. After the solvent was evaporated, the residue was washed, filtered and separated, and dried in vacuo to obtain the halogenated-1-hydrocarbyl- 3-vinyl-2,4,5-triaryl imidazoles.
优选,在以上2项中所述的方法中,1-乙烯基-2,4,5-三芳基咪唑和卤代烃R4X(如碘甲烷)的投料摩尔比为1:0.1~10,优选1:0.5~5,更优选1:1.2~1.8,进一步优选约1:1.5。Preferably, in the method described in the above two items, the molar ratio of 1-vinyl-2,4,5-triaryl imidazole and halogenated hydrocarbon R 4 X (such as methyl iodide) is 1:0.1-10, Preferably it is 1:0.5-5, more preferably 1:1.2-1.8, still more preferably about 1:1.5.
优选,在以上2项中所述的方法中,所述溶剂是醚类溶剂例如四氢呋喃、二噁烷;酮类溶剂例如丙酮、丁酮;或烃类溶剂例如二氯甲烷;或酯类溶剂例如醋酸乙酯;优选为四氢呋喃。Preferably, in the method described in the above 2 items, the solvent is an ether solvent such as tetrahydrofuran, dioxane; a ketone solvent such as acetone, butanone; or a hydrocarbon solvent such as methylene chloride; or an ester solvent such as Ethyl acetate; preferably tetrahydrofuran.
3、在以上2项中所述的方法中,优选的是,其中通式(II)的N-乙烯基三芳基咪唑化合物是通过由包括以下步骤的制备方法所制备的:3. In the method described in the above 2 items, it is preferred that the N-vinyl triaryl imidazole compound of the general formula (II) is prepared by a preparation method comprising the following steps:
(A)将联苯甲酰、苯甲醛、醋酸铵、乙醇胺和纳米Fe3O4磁流体的混合物在溶剂中加热回流,反应结束后冷却,重结晶后获得N-羟乙基-2,4,5-三芳基咪唑;(A) Heat the mixture of dibenzoyl, benzaldehyde, ammonium acetate, ethanolamine and nano-Fe 3 O 4 magnetic fluid to reflux in a solvent, cool down after the reaction, and obtain N-hydroxyethyl-2,4 after recrystallization ,5-triaryl imidazole;
(B)让N-羟乙基-2,4,5-三芳基咪唑与三溴化磷升温反应,反应后冷却,经重结晶后获得N-溴乙基-2,4,5-三芳基咪唑;(B) Let N-hydroxyethyl-2,4,5-triaryl imidazole react with phosphorus tribromide, cool after reaction, and obtain N-bromoethyl-2,4,5-triaryl after recrystallization imidazole;
(C)让N-溴乙基-2,4,5-三芳基咪唑)与碱(例如氢氧化钾或氢氧化钠)回流反应,进行分离(例如柱分离),获得通式(II)的N-乙烯基三芳基咪唑化合物。(C) let N-bromoethyl-2,4,5-triaryl imidazole) and base (such as potassium hydroxide or sodium hydroxide) reflux reaction, carry out separation (such as column separation), obtain general formula (II) N-vinyl triaryl imidazole compounds.
4、在以上3项所述的方法中,在步骤(A)中,联苯甲酰、苯甲醛、醋酸铵、乙醇胺四者的摩尔比是0.5~1.5:0.5~1.5:0.5~1.5:0.5~1.5,优选0.8~1.2:0.8~1.2:0.8~1.2:0.8~1.2;和/或4. In the method described in the above 3 items, in step (A), the molar ratio of dibenzoyl, benzaldehyde, ammonium acetate and ethanolamine is 0.5~1.5:0.5~1.5:0.5~1.5:0.5 ~1.5, preferably 0.8~1.2: 0.8~1.2: 0.8~1.2: 0.8~1.2; and/or
在步骤(B)中,N-羟乙基-2,4,5-三芳基咪唑与三溴化磷的摩尔比是1:1~4,优选1:1.5~2.5;和/或In step (B), the molar ratio of N-hydroxyethyl-2,4,5-triaryl imidazole to phosphorus tribromide is 1:1-4, preferably 1:1.5-2.5; and/or
在步骤(C)中,N-溴乙基-2,4,5-三芳基咪唑)与碱的摩尔比是1:2~6,优选1:3~4。In step (C), the molar ratio of N-bromoethyl-2,4,5-triaryl imidazole) to base is 1:2-6, preferably 1:3-4.
5、本发明的卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑,如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑,可有效提高反应产率,并且可作为中间体或最终产物应用于有机合成、药物合成、农药、造纸及功能材料等领域。5. Halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazoles of the present invention, such as iodide-1-methyl-3-vinyl-2,4,5-triaryl imidazoles, It can effectively improve the reaction yield, and can be used as an intermediate or final product in the fields of organic synthesis, drug synthesis, pesticides, papermaking, and functional materials.
以四氢呋喃溶剂为例,本发明的方法包括:Taking tetrahydrofuran as an example, the method of the present invention comprises:
将1-乙烯基-2,4,5-三芳基咪唑和碘甲烷加入无水四氢呋喃中,搅拌均匀后加热到50~70℃,优选60~65℃并将反应液进行保温反应直至反应结束,将回流装置改为蒸馏装置,蒸除溶剂后,残余物加入到大量的乙醚中洗涤,然后过滤分离、真空干燥箱干燥得到碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑。Add 1-vinyl-2,4,5-triaryl imidazole and iodomethane into anhydrous tetrahydrofuran, stir evenly, heat to 50-70°C, preferably 60-65°C, and keep the reaction solution warm until the reaction is completed. Change the reflux device to a distillation device. After the solvent is evaporated, the residue is added to a large amount of ether for washing, then filtered and separated, and dried in a vacuum oven to obtain iodide-1-methyl-3-vinyl-2,4,5 - Triaryl imidazoles.
化学反应方程式如下所示:The chemical reaction equation is as follows:
本发明以1-乙烯基-2,4,5-三芳基咪唑和碘甲烷加入溶剂(优选无水四氢呋)中共同作用,合成碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑,该方法操作简单,具有较高的实用价值。In the present invention, 1-vinyl-2,4,5-triaryl imidazole and iodomethane are added to a solvent (preferably anhydrous tetrahydrofuran) to act together to synthesize iodide-1-methyl-3-vinyl-2, 4,5-triaryl imidazole, the method is simple to operate and has high practical value.
1-乙烯基-2,4,5-三芳基咪唑和碘甲烷的投料摩尔比优选为1:1.2~1.8,尤其约1︰1.5,其中四氢呋喃作为溶剂,在该投料量下能够达到最佳催化效果。若投料量少于该配比,则反应不完全,或者反应速度过低;若投料量超过该配比,则造成不必要的浪费。The molar ratio of 1-vinyl-2,4,5-triaryl imidazole to methyl iodide is preferably 1:1.2 to 1.8, especially about 1:1.5, where tetrahydrofuran is used as a solvent, and the best catalytic performance can be achieved under this dosage Effect. If the amount of feed is less than the ratio, the reaction will be incomplete or the reaction rate is too low; if the amount of feed exceeds the ratio, unnecessary waste will be caused.
1-乙烯基-2,4,5-三芳基咪唑和无水四氢呋喃的投料比为1mol︰5~30L,优选1mol:15L,在该投料量下,产物产率最高。无水四氢呋喃的量少于该投料量时,整个溶液溶解效果不好,反应不完全;无水四氢呋喃的用量超过该投料量时,则会导致后处理时能耗过高。The feed ratio of 1-vinyl-2,4,5-triaryl imidazole to anhydrous tetrahydrofuran is 1mol:5-30L, preferably 1mol:15L, and the product yield is the highest under this feed amount. When the amount of anhydrous tetrahydrofuran is less than this amount, the dissolving effect of the whole solution is not good and the reaction is incomplete; when the amount of anhydrous tetrahydrofuran exceeds this amount, the energy consumption during post-processing will be too high.
所述保温反应时间为8~20小时,优选8~12小时,时间不足时,反应不彻底,实验表明在8~12小时的时间内,产物产率最高。The heat preservation reaction time is 8-20 hours, preferably 8-12 hours. If the time is insufficient, the reaction will not be complete. Experiments show that the product yield is the highest within 8-12 hours.
所述反应温度为60~65℃,低于此温度时,该反应速度较慢,实验表明60~65℃为最佳反应温度。Described reaction temperature is 60~65 ℃, when lower than this temperature, this reaction rate is slower, experiment shows that 60~65 ℃ is optimum reaction temperature.
所述以残余物加入到大量的乙醚中洗涤,然后过滤分离、真空干燥箱干燥得到碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑。如果洗涤的次数不够,则不能完全分离提纯产物。The residue was added to a large amount of diethyl ether for washing, and then separated by filtration and dried in a vacuum oven to obtain iodide-1-methyl-3-vinyl-2,4,5-triaryl imidazole. If the number of times of washing is not enough, the purified product cannot be completely separated.
本发明的优点和有益效果在于:Advantage and beneficial effect of the present invention are:
1.本发明的卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑,例如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑,作为离子液体可有效提高反应产率,并且可作为中间体或最终产物应用于有机合成、药物合成、农药、造纸及功能材料等领域。1. Halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triarylimidazoles of the present invention, such as iodide-1-methyl-3-vinyl-2,4,5-triarylimidazoles, As an ionic liquid, it can effectively improve the reaction yield, and can be used as an intermediate or final product in the fields of organic synthesis, drug synthesis, pesticides, papermaking, and functional materials.
2.本发明的反应条件温和,不需要传统的强酸或者强碱作为催化剂,操作简单,具有较高的实用价值。2. The reaction condition of the present invention is mild, does not need traditional strong acid or strong base as a catalyst, is simple to operate, and has high practical value.
3.本发明方法在一个反应体系中得到卤化-1-烃基-3-乙烯基-2,4,5-三芳基咪唑,例如碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑。3. The method of the present invention obtains halogenated-1-hydrocarbyl-3-vinyl-2,4,5-triaryl imidazoles in a reaction system, such as iodide-1-methyl-3-vinyl-2,4, 5-triaryl imidazoles.
4.本发明方法的反应时间短,并且在无水四氢呋喃中反应,对环境友好,无污染。4. The reaction time of the method of the present invention is short, and the reaction is performed in anhydrous tetrahydrofuran, which is environmentally friendly and has no pollution.
附图说明Description of drawings
图1为实施例1的单体N-乙烯基-2,4,5-三苯基咪唑的核磁氢谱图;Fig. 1 is the NMR spectrum of the monomer N-vinyl-2,4,5-triphenylimidazole of embodiment 1;
图2为实施例1的单体N-乙烯基-2,4,5-三苯基咪唑的核磁碳谱图;Fig. 2 is the carbon nuclear magnetic spectrogram of the monomer N-vinyl-2,4,5-triphenylimidazole of embodiment 1;
图3是实施例2所得化合物的1H核磁共振谱图。Fig. 3 is the 1 H nuclear magnetic resonance spectrum of the compound obtained in Example 2.
图4是实施例2所得化合物的13C核磁共振谱图。Fig. 4 is the 13 C nuclear magnetic resonance spectrum of the compound obtained in Example 2.
具体实施方式Detailed ways
以下具体实施例对本发明作进一步详细的说明,但实施例并不对本发明做任何形式的限定。除非特别说明,本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。The following specific examples illustrate the present invention in further detail, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the technical field.
实施例1Example 1
单体N-乙烯基-2,4,5-三苯基咪唑的结构式分别如下所示:The structural formulas of monomer N-vinyl-2,4,5-triphenylimidazole are as follows:
单体:monomer:
以上单体的合成路线The synthetic route of the above monomers
(1)N-羟乙基-2,4,5-三苯基咪唑(1) N-Hydroxyethyl-2,4,5-triphenylimidazole
在500ml圆底烧瓶中在加入42.05g(200mmol)联苯甲酰、21.22g(200mmol)苯甲醛、15.42g(200mol)醋酸铵、12.22g(200mmol)乙醇胺和纳米Fe3O4磁流体的混合物加热,用350mL乙醇溶解,加热回流。用薄层色谱法跟踪反应结束后,冷却至室温。将反应液缓慢倒入大量冷水中,抽滤。所得固体用乙酸乙酯重结晶,得到白色固体。然后柱色谱分离(乙酸乙酯:石油醚=7:3),产率:78%。In a 500ml round bottom flask, add 42.05g (200mmol) dibenzoyl, 21.22g (200mmol) benzaldehyde, 15.42g (200mol) ammonium acetate, 12.22g (200mmol) ethanolamine and nano Fe 3 O 4 The mixture of magnetic fluid Heat, dissolve with 350mL ethanol, and heat to reflux. After the completion of the reaction was tracked by thin layer chromatography, it was cooled to room temperature. The reaction solution was slowly poured into a large amount of cold water, and filtered with suction. The resulting solid was recrystallized from ethyl acetate to give a white solid. Then column chromatography (ethyl acetate:petroleum ether=7:3), yield: 78%.
(2)N-溴乙基-2,4,5-三苯基咪唑(2) N-bromoethyl-2,4,5-triphenylimidazole
在500mL的圆底烧瓶中用300mL DMF溶解35.4g(87.0mmol)化合物(N-羟乙基-2,4,5-三苯基咪唑)。冰浴至0℃后,缓慢滴加16.5mL(174mmol)三溴化磷。滴加完毕,升温至80℃搅拌反应5h。反应停止后,冷却至室温,加入氨水使反应液呈弱碱性。然后将反应液倒入大量冷水中,抽滤,固体用蒸馏水洗涤。将粗产物用乙酸乙酯重结晶后得白色固体38.6g,产率94.3%。35.4 g (87.0 mmol) of the compound (N-hydroxyethyl-2,4,5-triphenylimidazole) was dissolved in 300 mL of DMF in a 500 mL round bottom flask. After ice cooling to 0°C, 16.5 mL (174 mmol) of phosphorus tribromide was slowly added dropwise. After the dropwise addition was completed, the temperature was raised to 80° C. and the reaction was stirred for 5 h. After the reaction stopped, it was cooled to room temperature, and ammonia water was added to make the reaction solution weakly alkaline. Then the reaction solution was poured into a large amount of cold water, filtered with suction, and the solid was washed with distilled water. The crude product was recrystallized from ethyl acetate to obtain 38.6 g of a white solid with a yield of 94.3%.
(3)N-乙烯基-2,4,5-三苯基咪唑(3) N-vinyl-2,4,5-triphenylimidazole
在500mL的圆底烧瓶中用300mL乙醇溶解38.6g(82.1mmol化合物(N-溴乙基-2,4,5-三苯基咪唑)和16.8g(300mmol)氢氧化钾。回流反应5h,冷却至室温后将反应液倒入冷水中,抽滤,固体用蒸馏水洗涤。粗产物以乙酸乙酯/石油醚(体积比为1:1)为洗脱剂进行过柱分离,得29.8g白色固体,产率93.4%。图1为该单体N-乙烯基-2,4,5-三苯基咪唑的核磁氢谱图;图2为该单体N-乙烯基-2,4,5-三苯基咪唑的核磁碳谱图。Dissolve 38.6g (82.1mmol of N-bromoethyl-2,4,5-triphenylimidazole) and 16.8g (300mmol) of potassium hydroxide in 300mL of ethanol in a 500mL round bottom flask. Reflux for 5h and cool After reaching room temperature, the reaction solution was poured into cold water, suction filtered, and the solid was washed with distilled water. The crude product was separated by column with ethyl acetate/petroleum ether (1:1 by volume) as the eluent to obtain 29.8g white solid , yield 93.4%.Fig. 1 is the NMR spectrum of the monomer N-vinyl-2,4,5-triphenylimidazole; Fig. 2 is the monomer N-vinyl-2,4,5- C NMR spectrum of triphenylimidazole.
在本实施例中取代基R1、R2、R3同时为氢。In this embodiment, the substituents R 1 , R 2 and R 3 are simultaneously hydrogen.
实施例2:碘化-1-甲基-3-乙烯基-2,4,5-三苯基咪唑的合成反应Example 2: Synthetic reaction of iodide-1-methyl-3-vinyl-2,4,5-triphenylimidazole
向50ml圆底烧瓶中依次加入反应原料1mmol 1-乙烯基-2,4,5-三苯基咪唑、1.5mmol碘甲烷及15mL无水四氢呋喃,搅拌均匀后加热到60~65℃并保温反应液至反应结束,反应12h。反应完成后,将回流装置改为蒸馏装置,蒸除无水四氢呋喃,残余物加入到大量的乙醚中洗涤,然后过滤分离、真空干燥箱干燥得到碘化-1-甲基-3-乙烯基-2,4,5-三苯基咪唑。碘化-1-甲基-3-乙烯基-2,4,5-三苯基咪唑的产率为87.2%。Add the reaction raw materials 1mmol 1-vinyl-2,4,5-triphenylimidazole, 1.5mmol methyl iodide and 15mL anhydrous tetrahydrofuran to a 50ml round-bottomed flask in sequence, stir well, heat to 60-65°C and keep the reaction liquid To the end of the reaction, react for 12h. After the reaction was completed, the reflux device was changed to a distillation device, and anhydrous tetrahydrofuran was evaporated, and the residue was added to a large amount of ether for washing, then separated by filtration, and dried in a vacuum oven to obtain iodide-1-methyl-3-vinyl- 2,4,5-Triphenylimidazole. The yield of iodide-1-methyl-3-vinyl-2,4,5-triphenylimidazole was 87.2%.
本发明的化学反应式为:Chemical reaction formula of the present invention is:
对上述合成反应经薄层层析所得到的产物进行分析鉴定:The product obtained by the above synthetic reaction through thin layer chromatography is analyzed and identified:
其中取代基R1、R2、R3同时为氢的以上通式的碘化-1-甲基-3-乙烯基-2,4,5-三芳基咪唑的理化性质鉴定:Identification of physical and chemical properties of the iodide-1-methyl-3-vinyl-2,4,5-triaryl imidazole of the above general formula in which the substituents R 1 , R 2 , and R 3 are hydrogen at the same time:
1.白色固体mp:113-115℃。1. White solid mp: 113-115°C.
2. 1H核磁共振谱分析:2. 1 H nuclear magnetic resonance spectrum analysis:
1H NMR(400MHz,DMSO-d6,δ,ppm)8.06(d,J=7.4Hz,2H),7.74(d,J=6.9Hz,2H),7.45(ddd,J=16.8Hz,6H),7.30–6.95(m,5H),6.82(dd,J=15.7,8.5Hz,1H),5.12(d,J=8.4Hz,1H),4.75(d,J=15.7Hz,1H). 1 H NMR (400MHz, DMSO-d 6 , δ, ppm) 8.06 (d, J=7.4Hz, 2H), 7.74 (d, J=6.9Hz, 2H), 7.45 (ddd, J=16.8Hz, 6H) ,7.30–6.95(m,5H),6.82(dd,J=15.7,8.5Hz,1H),5.12(d,J=8.4Hz,1H),4.75(d,J=15.7Hz,1H).
3. 13C核磁共振谱分析:3. 13 C nuclear magnetic resonance spectrum analysis:
13C NMR(100MHz,DMSO-d6,δ,ppm):132.89,132.10,131.66–131.21,131.07,130.80,130.48,129.87,129.60,129.35,129.04,125.99,125.75,122.59,121.94,34.95. 13 C NMR (100MHz, DMSO-d 6 , δ, ppm): 132.89, 132.10, 131.66–131.21, 131.07, 130.80, 130.48, 129.87, 129.60, 129.35, 129.04, 125.99, 125.755, 122.994, 134
本发明的应用Application of the invention
在100ml圆底烧瓶中在加入0.4205g(2mmol)联苯甲酰、0.2122g(2mmol)苯甲醛、0.1542g(2mol)醋酸铵、0.1222g(2mmol)乙醇胺、纳米Fe3O4磁流体的混合物加热,用40mL乙醇溶解,加热回流。用薄层色谱法跟踪反应结束后,冷却至室温。将反应液缓慢倒入大量冷水中,抽滤。所得固体用乙酸乙酯重结晶,得到白色固体。然后柱色谱分离(乙酸乙酯:石油醚=7:3),产率:78%。In a 100ml round bottom flask, add 0.4205g (2mmol) dibenzoyl, 0.2122g (2mmol) benzaldehyde, 0.1542g (2mol) ammonium acetate, 0.1222g (2mmol) ethanolamine, nano Fe 3 O 4 The mixture of magnetic fluid Heat, dissolve with 40mL ethanol, and heat to reflux. After the completion of the reaction was tracked by thin layer chromatography, it was cooled to room temperature. The reaction solution was slowly poured into a large amount of cold water, and filtered with suction. The resulting solid was recrystallized from ethyl acetate to give a white solid. Then column chromatography (ethyl acetate:petroleum ether=7:3), yield: 78%.
在100ml圆底烧瓶中在加入0.4205g(2mmol)联苯甲酰、0.2122g(2mmol)苯甲醛、0.1542g(2mol)醋酸铵、0.1222g(2mmol)乙醇胺、纳米Fe3O4磁流体和(0.01g)碘化-1-甲基-3-乙烯基-2,4,5-三苯基咪唑的混合物加热,用40mL乙醇溶解,加热回流。用薄层色谱法跟踪反应结束后,冷却至室温。将反应液缓慢倒入大量冷水中,抽滤。所得固体用乙酸乙酯重结晶,得到白色固体。然后柱色谱分离(乙酸乙酯:石油醚=4:1),产率:83%In the 100ml round bottom flask, add 0.4205g (2mmol) dibenzoyl, 0.2122g (2mmol) benzaldehyde, 0.1542g (2mol) ammonium acetate, 0.1222g (2mmol) ethanolamine, nano Fe 3 O 4 magnetic fluid and ( 0.01 g) the mixture of iodide-1-methyl-3-vinyl-2,4,5-triphenylimidazole was heated, dissolved in 40 mL of ethanol, and heated to reflux. After the completion of the reaction was tracked by thin layer chromatography, it was cooled to room temperature. The reaction solution was slowly poured into a large amount of cold water, and filtered with suction. The resulting solid was recrystallized from ethyl acetate to give a white solid. Then column chromatography (ethyl acetate:petroleum ether=4:1), productive rate: 83%
本反应中加入碘化-1-甲基-3-乙烯基-2,4,5-三苯基咪唑离子液体,反应物的产率从78%增加到83.2%。所得化合物的1H核磁共振谱图和13C核磁共振谱图分别参见图3和图4。Adding iodide-1-methyl-3-vinyl-2,4,5-triphenylimidazolium ionic liquid to this reaction increases the yield of the reactant from 78% to 83.2%. The 1 H NMR spectrum and the 13 C NMR spectrum of the obtained compound are shown in Fig. 3 and Fig. 4, respectively.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510808967.7A CN105272918B (en) | 2015-11-20 | 2015-11-20 | Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510808967.7A CN105272918B (en) | 2015-11-20 | 2015-11-20 | Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105272918A CN105272918A (en) | 2016-01-27 |
CN105272918B true CN105272918B (en) | 2018-08-24 |
Family
ID=55142818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510808967.7A Expired - Fee Related CN105272918B (en) | 2015-11-20 | 2015-11-20 | Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105272918B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107311932A (en) * | 2017-07-01 | 2017-11-03 | 中国科学院兰州化学物理研究所 | A kind of method for catalyzing and synthesizing 1 methylimidazole |
CN110407753B (en) * | 2019-07-21 | 2022-08-09 | 桂林理工大学 | Method for synthesizing pentaarylimidazolium salt from diaryl iodonium salt and imidazole |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646540A (en) * | 2002-04-05 | 2005-07-27 | 南阿拉巴马大学 | Functionalized ionic liquids, and methods of use thereof |
CN1884266A (en) * | 2006-07-06 | 2006-12-27 | 云南大学 | Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
CN101665462A (en) * | 2009-09-17 | 2010-03-10 | 中国科学院过程工程研究所 | Method for preparing vinylimidazole ionic liquid |
CN102382057A (en) * | 2011-08-19 | 2012-03-21 | 中国科学院西安光学精密机械研究所 | Zwitterion with imidazole cation and malononitrile anion structures as well as preparation method and application thereof |
CN102924384A (en) * | 2011-08-12 | 2013-02-13 | 财团法人工业技术研究院 | Vinyl group-containing imidazole derivative and use thereof in electroluminescent element |
CN104447560A (en) * | 2013-09-13 | 2015-03-25 | 中国科学院大连化学物理研究所 | Imidazolyl ionic liquid and application thereof in alkaline anion exchange membrane |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4081677B2 (en) * | 2003-05-21 | 2008-04-30 | 信越化学工業株式会社 | Resist material and pattern forming method |
-
2015
- 2015-11-20 CN CN201510808967.7A patent/CN105272918B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646540A (en) * | 2002-04-05 | 2005-07-27 | 南阿拉巴马大学 | Functionalized ionic liquids, and methods of use thereof |
CN1884266A (en) * | 2006-07-06 | 2006-12-27 | 云南大学 | Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
CN101665462A (en) * | 2009-09-17 | 2010-03-10 | 中国科学院过程工程研究所 | Method for preparing vinylimidazole ionic liquid |
CN102924384A (en) * | 2011-08-12 | 2013-02-13 | 财团法人工业技术研究院 | Vinyl group-containing imidazole derivative and use thereof in electroluminescent element |
CN102382057A (en) * | 2011-08-19 | 2012-03-21 | 中国科学院西安光学精密机械研究所 | Zwitterion with imidazole cation and malononitrile anion structures as well as preparation method and application thereof |
CN104447560A (en) * | 2013-09-13 | 2015-03-25 | 中国科学院大连化学物理研究所 | Imidazolyl ionic liquid and application thereof in alkaline anion exchange membrane |
Non-Patent Citations (5)
Title |
---|
Kristina M. Hugar,等.Imidazolium Cations with Exceptional Alkaline Stability: A Systematic Study of Structure−Stability Relationships.《J. Am. Chem. Soc.》.2015,第137卷(第27期),第8730-8737页. * |
Saikat Das Sharma,等.An efficient and one-pot synthesis of 2,4,5-trisubstituted and 1,2,4,5-tetrasubstituted imidazoles catalyzed by InCl3•3H2O.《Tetrahedron Letters》.2008,第49卷第2216-2220页. * |
The Correlation between Structure and Corrosion Inhibition Activity of 4,5-Diphenyl-1-vinylimidazole Derivative Compounds towards Mild Steel in 1% NaCl Solution;Deana Wahyuningrum,等;《Int. J. Electrochem. Sci.》;20071220;第3卷(第14期);第154-166页 * |
Uber eine neue Synthese von Tetraaryl-imidazolen und Pentaarylimidazolium-Salzen;Jurgen Heinze,等;《Chemische Berichte》;19861231;第101卷(第10期);第3504-3516页 * |
制备条件对自由基聚合固载酸性离子液体催化性能的影响;万辉,等;《南京工业大学学报(自然科学版)》;20090731;第31卷(第04期);第12-16页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105272918A (en) | 2016-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102796052B (en) | Paeonol-1,2,3-triazole compound having antifungal activity and preparation method thereof | |
CN102702096B (en) | Quinoline nitrile derivative with aggregation-induced emission performance | |
CN104447396B (en) | Benzoin oxime derivative and preparation method thereof | |
CN111499586B (en) | Synthesis method of 5,5' -triazene bridged bis (2-methyl-4-nitro-1, 2, 3-triazole) compound | |
CN108033922A (en) | A kind of preparation method of 3- acyl groups quinokysalines derivative | |
CN105272918B (en) | Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes | |
CN104356037A (en) | Method for preparing thioamide derivative | |
CN108218798B (en) | Preparation method of Apabetalone | |
CN102180877B (en) | Synthetic process of imidazo phenanthroline compound | |
CN105085320A (en) | Synthesis method of dicyano substituted biphenyl compounds | |
CN109384786B (en) | Imidazole-based isomer luminescent molecule and preparation method and application thereof | |
CN110078696B (en) | A 3-benzylidene-2-phenyl-2,3-dihydro-4H-1-benzopyran-4-one compound | |
CN104529903B (en) | The diphenyl-imidazole of 2 methyl 4,5 and 2, the synthetic method of 4,5 triphenyl-oxazoles | |
CN111909057A (en) | A kind of preparation method of cyclopentenyl aryl ketoxime compound | |
CN105859620B (en) | A class of 6-trichloromethylphenanthridine compounds and their preparation methods and applications | |
CN105294689B (en) | Tetra-substituted pyrazol isoquinoline compound and synthetic method thereof | |
CN105330663B (en) | A kind of pyrazoloisoquinoline compound and its synthetic method | |
CN103204845B (en) | Imidazolyl ionic liquid, and synthesizing method and application thereof | |
CN105399683B (en) | Benzimidazole derivatives and process for preparing the same | |
CN106279114A (en) | A kind of synthetic method of Taladegib | |
CN101775009B (en) | Composite method of itraconazole and refining method | |
CN104513203B (en) | The synthetic method of 3,4,5 triphenyl pyrazoles | |
CN104610033B (en) | A kind of four ketones derivants and its preparation method and application | |
CN119569663A (en) | A preparation method of 1-(3-bromo-4-methoxyphenyl)-3-(trifluoromethyl)-1,2,4-triazole | |
CN110878059A (en) | 4-benzylidene-2-arylisoxazolidine-3,5-dione and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180824 Termination date: 20201120 |
|
CF01 | Termination of patent right due to non-payment of annual fee |